Ptc Therapeutics, Inc. · NASDAQ:PTCT
Vanguard Portfolio Management LLC reported a 5.88% stake in Ptc Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.88% stake in Ptc Therapeutics, Inc., 4,871,329 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.88%
- Shares
- 4,871,329
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.88% | 4,871,329 |
Source
Related
- Ptc Therapeutics, Inc.
- Vanguard Portfolio Management LLC
- Ptc Therapeutics, Inc. shareholders
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026